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OBJECTIVES We sought to demonstrate the electrophysiologic (EP) mechanism of the ST-T change in
Brugada syndrome.
BACKGROUND Brugada syndrome is characterized by various electrocardiographic manifestations (e.g., right
bundle branch block, ST-segment elevation, and terminal T-wave inversion in the right
precordial leads) and sudden cardiac death caused by ventricular fibrillation. Direct evidence
in support of the EP mechanism underlying this intriguing syndrome has been lacking.
METHODS Monophasic action potentials (MAPs) were obtained from three patients with the coved-type
ST-segment elevation (Brugada patients) and five control patients using the contact electrode
method. Epicardial MAPs were recorded during open-chest surgery in all patients.
RESULTS A spike-and-dome configuration was documented from epicardial sites of the right ventric-
ular (RV) outflow tract in all Brugada patients but not in control patients. Monophasic action
potential recordings from the endocardium with special focus on the RV outflow tract could
not demonstrate any morphological abnormalities in three Brugada patients.
CONCLUSIONS The presence of a deeply notched action potential in the RV epicardium, but not in
endocardium, would be expected to induce a transmural current that would contribute to
elevation of the ST-segment in the right precordial leads. The spike-and-dome configuration
may also prolong the epicardial action potential, thus contributing to a rapid reversal of the
transmural gradients and inscription of an inverted T-wave. (J Am Coll Cardiol 2002;40:
330–4) © 2002 by the American College of Cardiology Foundation
In 1992, Brugada and Brugada described a distinct subtype
of idiopathic ventricular fibrillation (VF) by indicating
unique electrocardiographic (ECG) manifestations charac-
terized by right bundle branch block (late r wave or
J-wave), ST-segment elevation of the coved or saddle-back
type, and T-wave inversion in the right precordial ECG
leads V1 to V2 or V3 (1–3). Since that time, great interest
has been focused on the electrophysiologic (EP) mechanism
of the intriguing ST-T morphology in Brugada syndrome
(4–11). ST-segment elevation in Brugada syndrome has
been ascribed to delayed conduction within the right ven-
tricular (RV) outflow tract, accentuation of the action
potential notch, and/or loss of the action potential dome in
this region. Direct evidence in support of these EP mech-
anisms has been very limited and in some cases totally
lacking.
Recently, Yan and Antzelevitch (12) demonstrated that
depression or loss of action potential dome in the RV
epicardium creates a transmural voltage gradient, which may
lead to the ST-segment elevation in Brugada syndrome.
Furthermore, although a few studies have investigated the
repolarization property of Brugada syndrome by recording
endocardial monophasic action potentials (MAP) (13,14),
these were not able to completely explain the mechanism of
specific ST-segment elevation in this syndrome.
To assess the direct relationship of the morphologic
change in the epicardial cells on the ST-segment elevation
and the resultant T-wave inversion in Brugada syndrome,
we recorded MAPs from both endocardial and epicardial
sites of the RV in three patients with a Brugada-type ECG.
METHODS
Subjects
Three patients with typical ECG manifestations of Bru-
gada syndrome. Three patients with the typical ECG
manifestations of Brugada syndrome were included in the
present study. Patients’ clinical characteristics are shown in
Table 1. Electrocardiograms obtained during sinus rhythm
demonstrated a prominent coved-type ST-segment eleva-
tion followed by T-wave inversion in V1 to V2 (Fig. 1).
Ventricular fibrillation was documented in Patients 1 and 2
but not in Patient 3, who had only symptomatic paroxysmal
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atrial fibrillation. Although apparent organic heart disease
(ventricular septal defect) was detected in Patient 2, a gene
mutation of the cardiac sodium channel (SCN5A) was
identified in this patient as well. Open-chest surgery was
performed for various indications (Table 1). Epicardial
MAPs were recorded during surgery in all patients, and
endocardial MAPs were obtained during surgery (Patient 1)
or during the EP study (Patients 2 and 3), which was
performed several weeks before surgery.
Five control patients with ischemic heart disease. Five
male candidates for coronary artery bypass grafting were
selected as the control (Table 1). None of them had any
history of myocardial infarction, syncope, or significant
ventricular arrhythmia. Monophasic action potentials were
recorded only from the epicardial sites during surgery.
EP Study Protocol for the MAP Recording
Informed consent was obtained before the MAP recordings.
During constant right atrial pacing at a cycle length of 750
ms or 1,000 ms, MAPs were recorded by the contact
electrode method as previously described (13–19). The
MAPs and surface ECG leads were simultaneously re-
corded on a strip chart recorder (Siemens-Elema, Solna,
Sweden, 8 channel Mingograf) or a computer/recorder
system with optical disk storage (Quinton Electrophysi-
ologic Corp., Seattle, Washington). The MAPs were am-
plified and filtered at a frequency of 0.05–500 or 400 Hz and
were analyzed after placement of the catheter electrode in a
position that provided continuous recordings with a stable
amplitude (5 mV), smooth configuration, and isopotential
diastolic baseline (phase 4). The duration of MAP was
determined at 90% repolarization at each recording site.
Furthermore, the repolarization time was defined as the
time from the onset of QRS deflection to 90% repolariza-
tion of MAP (i.e., summation of a local activation time and
duration of MAP).
Endocardial MAP recordings. Endocardial MAP record-
ings were performed during the EP study (in Patients 2 and
3) or during open-chest surgery (in Patient 1). A 7-French
MAP-pacing combination catheter (EP Technologies,
Sunnyvale, California) was introduced through the femoral
vein or artery and advanced to RV or left ventricle (LV)
endocardium under fluoroscopic guidance. Monophasic ac-
tion potential recordings were made from widely separated
RV and LV endocardial sites (8 to 14 sites from the RV, 5
to 8 sites from the LV). An endocardial MAP from the LV
was not obtained in Patient 1.
Epicardial MAP recordings. Epicardial MAPs were re-
corded by a “spatula Franz” electrode especially designed to
obtain MAP during open-chest surgery (17). Immediately
after the thoracotomy, we recorded epicardial MAPs from
the RV anterior wall and LV anterior to lateral wall. Each
recording site was approximately 5 to 15 mm apart. Because
we had targeted the anterior surface of the RV, it was
bathed in 37°C saline to keep the heart surface warm and
close to body temperature.
RESULTS
Enodocardial and epicardial MAP recordings in three
patients with the Brugada-type ECG. PATIENT 1. In this
case, endocardial and epicardial MAPs (13 epicardial and 8
endocardial sites in the RV, 7 epicardial sites in the LV)
were recorded simultaneously. As shown in Figure 2, an
incomplete depolarization in phase 0 and excessive upstroke
in phase 2 of the epicardial MAP created a significant
spike-and-dome configuration. The morphology of the
MAP, which was simultaneously obtained from opposite
endocardial sites of the RV outflow tract, was completely
normal. Such an abnormal morphology of the MAP was
recorded from neighboring epicardial sites (over an approx-
imate 2-cm radius) of the RV outflow tract but not from
other sites. The duration of the MAP and repolarization















1 M 63 V1–V2  VF NA – ICD implant
2 M 54 V1–V2  VF  VSD VSD closure
3 M 59 V1–V2 – AF NA – Maze
Control
1 M 67 – – – NA CAD CABG
2 M 72 – – – NA CAD CABG
3 M 52 – – – NA CAD CABG
4 M 56 – – – NA CAD CABG
5 M 58 – – – NA CAD CABG
AF  atrial fibrillation; CABG  coronary artery bypass grafting; CAD  coronary artery disease; ECG  electrocardiogram; ICD  implantable cardioverter defibrillator;
M  male; NA  not assessed; SCN5A  cardiac sodium channel; VF  ventricular fibrillation; VSD  ventricular septal defect.
Abbreviations and Acronyms
ECG  electrocardiogram/electrocardiographic
EP  electrophysiologic study/electrophysiologic
LV  left ventricle/ventricular
MAP  monophasic action potential
RV  right ventricular/ventricle
VF  ventricular fibrillation
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time in the epicardial site were apparently longer than those
in the endocardial site (duration of MAP, 310 ms vs. 250
ms; repolarization time, 400 ms vs. 325 ms, respectively).
PATIENT 2. During the EP study, endocardial MAPs were
obtained from 22 sites (14 from the RV, 8 from the LV),
but no abnormal configurations of MAPs were observed
during the endocardial mapping. Epicardial MAPs were
recorded from 35 sites (25 from the RV, 10 from the LV)
during surgery. Epicardial MAPs obtained from the free
wall of the RV outflow tract demonstrated a spike-and-
dome configuration, as observed in Patient 1. Repeated
MAP recordings from the same site and neighboring areas
showed a particular configuration of MAP within an area of
2 to 3 cm under the pulmonary valve.
PATIENT 3. During the EP study, endocardial MAPs were
obtained from 16 sites (11 from the RV, 5 from the LV).
No abnormal configurations of MAPs were observed during
the endocardial mapping. Epicardial MAPs were recorded
from 18 sites (12 from the RV, 6 from the LV) during the
Maze procedure surgery. A spike-and-dome configuration
was observed from the epicardium of the RV outflow tract
but not from the endocardium.
Epicardial MAP recordings in five control patients.
Epicardial MAPs were obtained from both ventricles during
the coronary artery bypass surgery. We recorded from 5 to
13 epicardial sites of both ventricles in each patient (mean of
9 sites) with special focus on the RV outflow tract. As
shown in Figure 2, no abnormal MAPs, such as those with
a spike-and-dome configuration, were demonstrated in any
of the control patients.
DISCUSSION
Major findings. We demonstrated an abnormal spike-and-
dome configuration of the epicardial MAPs obtained from
the RVOT in three patients with the Brugada-type ECG.
Incomplete depolarization during phases 0 and 1, and a
deep notch in phase 2, induced a transmural current from
the endocardium to the epicardium, which created a prom-
inent J point (ST-segment) elevation. The subsequent dome
produced a rapidly attenuated transmural current flow that
contributed to a steep downslope (coved-type) of the ST-
segment. Furthermore, a MAP and repolarization of longer
duration in the epicardium than in the endocardium, result-
ing from a delayed dome formation, suggested a reversal
current flow during phase 3 of the action potential. The
longer duration of action potential in the epicardium may
have created the typical terminal T-wave inversion observed
in Brugada syndrome.
The mechanism of the ST segment elevation in Brugada
syndrome. Yan and Antzelevitch (12) suggested that a loss
of the action potential dome at the epicardium but not at the
endocardium creates a transmural voltage gradient that may
Figure 1. Twelve-lead electrocardiogram (ECG) tracings in three patients with a Brugada-type ECG. All patients exhibited typical (coved-type) ST
segment elevation and terminal T-wave inversion in the right precordial ECG leads (V1 and V2). An apparent right bundle branch block pattern and left
axial deviation suggesting interventricular conduction delay are observed in Patients 1 and 2.
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be responsible for the ST-segment elevation. This sole EP
mechanism properly accounts for not only the ST-segment
elevation but also the premature ventricular contraction
(phase 2 reentry) and reentrant substrate for VF in Brugada
syndrome (4–6,12).
In the present study, we documented the spike-and-dome
configuration of the epicardial MAP but could not demon-
strate a markedly shortened duration of MAP. However,
this result is also compatible with the ECG manifestations
of Brugada syndrome. Furthermore, a similar abnormal
morphology of the action potential has been reported in a
canine experimental model under proper conditions (fle-
cainide infusion) (20). Considering the fact that mutations
in the genes encode the cardiac sodium channels (SCN5A)
and that the class Ic drug either augmented or uncovered
ST-segment elevation in Brugada syndrome (1,21–25),
spike-and-dome configuration of the action potential is
highly possible in the clinical situation.
Site specificity of abnormal MAP in Brugada syndrome.
In Brugada syndrome, typical ST-segment elevation is
frequently recognized in leads V1 through V3 of the stan-
dard 12-lead ECG (1–14,26–28). As previously described,
such a distribution indicates that the EP abnormality is
located in the area around the RV outflow tract (14,28,29).
In the present study, the epicardial area with a morphologic
change of the MAP was compatible with the typical
Brugada-ECG manifestations. Disparity in the magnitude
of Ito and significant notch formation during phases 0 and 1
of the RV epicardium has been reported (30). Such an
intrinsic heterogeneity may be pronounced under particular
conditions such as that with suppression of the sodium
channels (7,23,27).
Study limitations. In two patients with the Brugada-type
ECG, endocardial and epicardial MAPs were not recorded
simultaneously. Therefore, we could not compare the dura-
tion of MAP and the local repolarization time between the
epicardium and the endocardium, except for Patient 1.
Because of the open-chest surgery, the precordial ECG
leads (V1 to V3) could not be obtained during the epicardial
MAP recording. However, we confirmed that the patients
showed the typical Brugada ECG immediately before the
chest wall sterilization in the operation room.
Although we could not completely exclude the possibility
that spike-and-dome configuration of the MAP was a
recording artifact, it seems unlikely, because the MAP
recording maintained a stable configuration throughout the
procedures and no abnormal configuration of the MAP was
recorded in any of the control patients. The MAP recording
technique has usually been utilized to demonstrate the
action potential duration or phase 3 abnormalities such as
early after-depolarization (18,19). However, theoretically,
the MAP should reveal any abnormal configuration of
phases 1 and 2 of the action potential if it really exists
(15,16).
The MAP cannot be used to evaluate the absolute degree
of transmembrane potential (16). Our assessment of the
transmural current flow indicating the ST-T segment
change in Brugada syndrome is therefore not based on
direct measurements of the transmembrane potential.
Clinical implication. If the EP substrates for VF are
restricted within the epicardial area of the RV outflow tract,
a radical therapy such as cryosurgery may be possible for
Brugada syndrome, especially in patients with multiple VF
episodes after implantable cardioverter defibrillator therapy
(9,26).
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